US To Dump 60 Million Unapproved Blood Clot Causing AstraZeneca COVID-19 Vaccines On India | GreatGameIndia

us-to-dump-60-million-unapproved-blood-clot-causing-astrazeneca-covid-19-vaccines-on-india-|-greatgameindia

28-04-21 09:26:00,

The US is planning to dump 60 million doses of the AstraZeneca vaccines on India to help us fight COVID-19. These AstraZeneca vaccines however is unapproved for use in the US and hence the unwanted stock is being offloaded on Indians. Moreover, this comes at a time when numerous European countries have stopped or suspended the use of AstraZeneca’s vaccine for causing bood clots and are launching lawsuits against the company.

US To Dump 60 Million Unapproved Blood Clot Causing AstraZeneca COVID-19 Vaccines On India

The U.S. will begin sharing its entire stock of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews, the White House said Monday, with as many as 60 million doses expected to be available for export in the coming months.

The AstraZeneca vaccine has not yet been authorized by the U.S. Food and Drug Administration.

“Given the strong portfolio of vaccines that the U.S. already has and that have been authorized by the FDA, and given that the AstraZeneca vaccine is not authorized for use in the U.S., we do not need to use the AstraZeneca vaccine here during the next several months,” said White House COVID-19 coordinator Jeff Zients.

“Therefore the U.S. is looking at options to share the AstraZeneca doses with other countries as they become available.”

US is planning to dump 60 Million doses of #AstraZeneca vaccines on India. These are not approved for use in their own country and are suspended for use in Europe. Germany scientists found exact 2 step process how they cause blood clots https://t.co/NlpjKmcZg3 pic.twitter.com/xonaX7zLlu

— GreatGameIndia (@GreatGameIndia) April 27, 2021

Moreover, AstraZeneca’s doses in the U.S. were produced at an Emergent BioSolutions plant in Baltimore that has come under increased regulatory and public scrutiny after botching batches of the J&J vaccine.

The U.S. pressed J&J to take over the plant and, as part of the effort to ensure the quality of newly produced vaccines, directed the facility to stop making the AstraZeneca shot.

AstraZeneca is still looking to identify a new U.S. production facility for its future doses.

Numerous European countries have suspended or stopped the use of AstraZeneca’s vaccines for causing blood clots and are now in the process of launching legal action against the company.

 » Lees verder

%d bloggers liken dit: